Clinical Trial Update: An Study to Investigate the Efficacy of Delta-9-tetrahydrocannabinol (THC) and Cannabidiol (CBD) in Multiple Sclerosis [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating THC and CBD in multiple sclerosis completed with results posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• Delta-9-tetrahydrocannabinol (THC) and Cannabidiol (CBD) combination

Snippet

Sponsor: Jazz Pharmaceuticals | Conditions: Multiple Sclerosis | Phase 3 | Status: COMPLETED | Results posted: 2012-09-19